Alivus Life Sciences

1,037.00
+3.90
(0.38%)
Market Cap
12,716.64 Cr
EPS
39.63
PE Ratio
26.02
Dividend Yield
0.48 %
Industry
Healthcare
52 Week High
1,251.00
52 Week Low
850.00
PB Ratio
4.49
Debt to Equity
0.01
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,681.70
#1 4,03,496.16
35.11
#1 52,041.20
12.06
#1 10,980
-18.99
49.60
6,917.50
1,83,637.89
83.20
9,360.00
0.89
2,117
23.05
67.24
1,515.50
1,22,408.12
23.68
28,409.50
7.12
5,291
30.28
52.75
3,365.90
1,13,917.35
58.56
11,317.00
11.59
2,054
10.91
59.08
1,289.00
1,07,576.21
19.45
33,741.20
12.36
5,725
21.14
49.51
1,004.45
1,01,071.17
21.53
22,573.80
13.82
3,977
-0.19
69.48
2,421.90
99,958.78
49.11
12,207.40
19.57
1,925
-10.91
49.97
1,986.00
90,699.72
27.22
22,192.10
#1 19.94
3,024
#1 112.49
47.26
35,345.00
75,105.66
53.31
6,409.15
10.80
1,417
27.83
71.69
1,178.90
68,470.70
#1 19.42
31,378.10
17.55
3,366
-0.50
55.14

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
4.80 %
Net Income Growth
0.84 %
Cash Flow Change
35.13 %
ROE
-7.55 %
ROCE
-8.03 %
EBITDA Margin (Avg.)
-2.45 %

Yearly Financial Results

Annual Financials
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
0
887
1,549
1,886
2,138
2,190
2,295
2,387
Expenses
0
639
1,065
1,294
1,507
1,519
1,609
1,704
EBITDA
0
248
484
592
631
671
686
683
Operating Profit %
-5 %
28 %
31 %
31 %
29 %
30 %
30 %
29 %
Depreciation
0
19
29
33
38
42
54
61
Interest
0
1
34
88
28
1
2
2
Profit Before Tax
0
228
421
471
565
629
631
654
Tax
0
33
108
119
146
162
160
162
Net Profit
-0
196
313
352
419
467
471
492
EPS in ₹
-7.89
24.64
29.04
32.61
35.63
38.11
38.43
39.63

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
0
1,475
1,726
1,997
2,471
2,702
2,850
3,411
Fixed Assets
0
456
546
573
590
781
805
1,057
Current Assets
0
931
1,160
1,399
1,765
1,850
1,916
2,335
Capital Work in Progress
0
80
11
14
97
62
106
94
Investments
0
0
0
0
0
0
0
674
Other Assets
0
939
1,169
1,410
1,784
1,860
1,939
0
Total Liabilities
0
1,475
1,726
1,997
2,471
2,702
2,850
3,411
Current Liabilities
2
1,380
1,308
1,221
384
497
439
470
Non Current Liabilities
0
7
16
23
33
67
79
124
Total Equity
-1
88
402
753
2,054
2,138
2,332
2,817
Reserve & Surplus
-1
86
400
751
2,030
2,114
2,308
2,793
Share Capital
0
2
2
2
25
25
25
25

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
2
8
106
397
-228
18
Investing Activities
0
-9
-51
-69
-122
-147
-117
Operating Activities
-1
10
195
388
598
306
414
Financing Activities
1
1
-137
-214
-79
-388
-279

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 21 42 22.5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 5.49 5.41 2.08 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,102.20 1,206.20
23 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jan 2025 1,075.80 1,173.30
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Oct 2024 1,123.35 1,041.00
09 Oct 2024 CHANGE OF NAME Change Of Name
NA
09 Oct 2024 1,201.90 1,201.90
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 1,093.00 1,057.60
17 Oct 2023 DIVIDEND Dividend
₹ 22.50 /share
17 Oct 2023 623.60 631.10
24 Mar 2023 DIVIDEND Dividend
₹ 21.00 /share
24 Mar 2023 387.40 391.95
17 Sept 2022 DIVIDEND Dividend
₹ 10.50 /share
15 Sept 2022 488.30 418.95
23 Nov 2021 DIVIDEND Dividend
₹ 10.50 /share
22 Nov 2021 633.05 619.95

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication9 days ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 30, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 30, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 16, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 15, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2025
Appointment Of Secretarial AuditorMay 15, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 15, 2025
Corporate Action-Board to consider DividendMay 15, 2025
Board Meeting Outcome for Audited Financial Results For The Fourth Quarter And Year Ended March 31 2025May 15, 2025
Audited Financial Results For The Fourth Quarter And Year Ended March 31 2025May 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 08, 2025
Closure of Trading WindowMay 08, 2025
Board Meeting Intimation for To Consider And Approve The Audited Financial Results Of The Company For The Quarter And Year Ended 31St March 2025 And To Consider And Recommend Dividend If Any On Equity Shares For The Year Ended March 31 2025.May 08, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 08, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 30, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 17, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 03, 2025
Announcement under Regulation 30 (LODR)-AcquisitionApr 02, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 03, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 27, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 21, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 31, 2025
Transcript Of Earnings Call.Jan 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 23, 2025
Integrated Filing (Financial)Jan 23, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 23, 2025
Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31 2024Jan 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 17, 2025
Closure of Trading WindowJan 16, 2025
Board Meeting Intimation for Inter Alia To Consider And Approve The Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended 31St December 2024Jan 16, 2025
Announcement under Regulation 30 (LODR)-Change of Company NameDec 17, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportNov 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 27, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 25, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 22, 2024
Transcript Of Earning CallOct 31, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 28, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 26, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 25, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 25, 2024

Technical Indicators

RSI(14)
Neutral
53.21
ATR(14)
Volatile
31.90
STOCH(9,6)
Neutral
46.49
STOCH RSI(14)
Overbought
89.41
MACD(12,26)
Bullish
4.68
ADX(14)
Weak Trend
8.51
UO(9)
Bearish
48.72
ROC(12)
Uptrend And Accelerating
1.98
WillR(14)
Overbought
-17.69

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Quant Small Cap Fund Direct Plan-Growth
0.46%
169092
0.01%
0.17%
Union ELSS Tax Saver Fund Direct-Growth
0.81%
-20979
-0.35%
-0.34%
Union Value Fund Direct - Growth
1.10%
-6383
-0.36%
-0.38%
Navi Aggressive Hybrid Fund Direct - Growth
0.95%
-1608
-0.26%
-0.23%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.17%
733
-0.02%
-0.02%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.17%
438
-0.03%
-0.03%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.17%
308
-0.03%
-0.03%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.18%
-233
-0.03%
-0.03%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.17%
199
-0.03%
-0.03%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.02%
126
0.00%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.17%
89
-0.03%
-0.03%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.17%
72
-0.03%
-0.03%
Groww Nifty Smallcap 250 Index Fund Direct - Growth
0.17%
28
-0.03%
-0.03%
Kotak Nifty Smallcap 250 Index Fund Direct-Growth
0.17%
28
-0.03%
-0.02%
Axis Nifty 500 Index Fund Direct-Growth
0.01%
-24
0.00%
0.00%
Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth
0.04%
11
-0.01%
0.00%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.04%
7
-0.01%
-0.01%
ICICI Prudential Nifty 500 Index Fund Direct-Growth
0.02%
4
0.00%
0.00%
SBI Nifty 500 Index Fund Direct-Growth
0.02%
-4
0.00%
0.00%
Angel One Nifty Total Market Index Fund Direct - Growth
0.02%
3
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.02%
2
0.00%
0.00%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.17%
-1
-0.02%
-0.03%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.25%
1
-0.02%
-0.02%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.00%
0
0.00%
0.00%
Tata Small Cap Fund Direct - Growth
0.62%
0
-0.12%
-0.12%